Home > News > Zyvex Continues to Exceed Sales Expectations
January 26th, 2005
Zyvex Continues to Exceed Sales Expectations
Zyvex today announced financial results for its fiscal 2004 fourth quarter. The Texas company continues its business gains with nine consecutive quarters of sales growth and expansion of its global sales reach.
Total revenue for the fourth quarter was $4.0 million, which was a 55 percent increase over the same period in 2003.
The total revenue for 2004 was $8.6 million, which represented a 102 percent increase over 2003. International sales, new to the company during 2004, accounted for 10 percent of the year’s revenue.
Simon Fraser University Completes Installation of Electron Microscopes from FEI: SFU’s new multi-million-dollar Centre for Soft Materials now offers the most advanced suite of microscopes in Western Canada March 11th, 2014
Harris & Harris Group Notes D-Wave's Article in Phys.Org March 11th, 2014
Malvern specialist to explore use of Nanoparticle Tracking Analysis for characterizing extracellular vesicles at ISEV 2014 March 11th, 2014
Thailand's Next Move on Research and Innovation March 11th, 2014
Arrowhead Reports Fiscal 2014 First Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time February 4th, 2014
Arrowhead to Report Fiscal 2014 First Quarter Financial Results - Conference Call Scheduled for Tuesday, February 4, 2014 January 28th, 2014
Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 4, 2014 January 15th, 2014
Nanobiotix 2013 Review: Significant Corporate and Clinical Progress January 7th, 2014